GW493838
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GW493838, covering 2013-02-12 to 2013-02-12. Get the full timeline:
Most recent: Clinical Trial Update: The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain [Phase 2]